RxDoctor Payments Data

Noel Patel, DPM

Foot Surgery · Richmond, VANPI 1922035815

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Amgen at 27.9% of the total. Reporting peaked in 2022 at $1,212 and has fallen 51.2% since, to $592 in 2025.

$5,026in general payments, 2019–2025

Across 78 payments — averaging $64.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1K
  • Stryker$635
  • AbbVie$577
  • Paratek Pharmaceuticals, Inc.$471
  • Smith+Nephew$339
  • Cardiovascular Systems Inc.$169
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$5,010100%
  • Education$160%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,026 in reported general payments places this provider in the 70th percentile of 34 foot surgery providers in Virginia.

See all foot surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$304,961
Medicare patients
386
Services billed
3,821

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate276$6,401
Griseofulvin Ultramicrosize20$4,379
Ketoconazole69$1,513
Diclofenac Sodium72$865
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav17$735
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip11$399
Ciclopirox18$283
Mupirocin33$277
Prednisone13$29

Paid to pharmacies, not to this prescriber.

Other foot surgery in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →